Travere Therapeutics SVP, Chief Accounting Officer Sandra Calvin disposes of $335,983 in common shares
Sandra Calvin, SVP and chief accounting officer, sold 5,375 Travere Therapeutics common shares on Sep. 15, 2026. Sales priced between $62.14 and $63.66 per share. * She exercised employee stock options for 5,375 shares at $20.46 to $27.5. Beneficial ownership ended at 42,353 common shares. Disclaimer: This news brief w